||EPS - Basic
||Market Cap (m)
|Electronic & Electrical Equipment
Oxford Instruments Share Discussion Threads
Showing 651 to 674 of 675 messages
|Time to add ?|
|That does not apply to the non execs, it's Chairman and non exec dealings
I tend to focus on.
ATM it's a case of silence is golden golden golden on that front, but the share price looks far from precious.|
|If you are a director of a company , you already have your income directly dependent on the company's fortunes , you have share options as well , so why risk your savings too. If I was a director I would put my cash elsewhere , even if I believed that the company was seriously undervalued. Eggs in baskets. Thus the directors share trading has always seemed a bit dubious as a guide to me...
But as you allude , there have been no significant director buys this calendar year. But no sales either!|
|Any directors buying these levels?.|
|The dividend should not have been maintained imv,
debt reduction should be the first, second and third priority here.|
|Blown loads of money on over priced acquisitions......|
|Net debt looks ugly IMV.|
|I see Numis has reduced its target price from 880p to 815p. I expect the new chairman to invigorate the company but it may take some time before the effects are clear.
|I missed that . Agree the price fall seems unrelated. Good trading share for the brave!
Looking ahead, we expect the second half to benefit from a normal seasonal bias, assisted by favourable currency benefits and the delivery of further business efficiency improvements. Taking into account our current pipeline and improved order book, the Board continues to expect that we will make progress in the year and we remain well positioned to take advantage from future growth in our markets|
|Steady enough AGM statement-not sure there is anything there to warrant a price fall.|
|Diddly squat ; suggest filter the ramper .|
|What's that got to do with OXIG?|
|REDS, remarkable recovery story not yet well known. Trading update 5th September.
REDS provides software applications for smart buildings and counts pharmaceutical giant GlaxoSmithKline and real estate player Meyer Bergman among its customers.
Constant flow of new contracts with large multinationals.
They got recently a 12 million contract with UBS which represented 50% of REDS' market capital! UBS have 700 more branches needing possibly the same service.
New CEO Mark Braund very positive and invested his own money along with the financial director. Mark is a specialist in turning around struggling companies. He has already done it with REDS in less than a year.
|Whats the share price saying now?|
|Sounds promising , not that you would notice from the share price . I suppose you have to see the share price as quite buoyant compared to the rest of the market in the last few weeks/months.|
|Two positives stand out in the figures. Order book year end up 12% and last year's cashflow, which meant that debt rose substantially less than the cost of the acquisitions. I suspect that the long term decline may be over now that the company has cut costs, rationalised and stripped out the less attractive businesses.
It would be nice to see the chart break through the two and a half year downtrend. Looks to be right at that point.....|
|Bought on this morning's rather odd dip. Feeling very smug now!|
|With the continuing slow share price slide , I have been looking at the latest broker guesses . They are quite conflicting , but the 2017 eps estimates of 47-56p look quite enticing now. Time to add?
I want to squeeze a few more pence lower though.|
Only just started looking at this one. I have read your comments on Austin, half yearly acc. and trading update. Thanks
Is there an opinion of how other ideas, potential products are developing? Do do you have ideas about how much growth there is to come with the NanoTech Tools business?
I am attracted to the company because the chart looks quite good considering all the bad news that is in the price.
Shall start Googling for technical/professional news.|
|Up 80p this afternoon , no news I can see.|
|Well it has smashed 600 anyway.
Oxford Instruments plc
Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, today issues a trading update for the period 1 October to 31 December 2015 ("the period").
Orders were ahead of the same period in the prior year, on both a reported and organic, constant currency basis. The trend seen in the first half of the year has continued with NanoTechnology Tools performing well, and ahead of last year, whilst Industrial Products has suffered from the continuing weakness of industrial markets. Service sector orders were ahead of the same period last year. The successful acquisition of the service business, MIR, earlier in the year has more than offset the effect of the completion of the Siemens MRI service contract in the prior year.
As expected, revenues for the period in NanoTechnology Tools and Service were marginally down on the same period last year on a constant currency organic basis following weaker long lead time order intake in previous periods. The order book for future deliveries is now ahead of the same period last year on a constant currency organic basis and has grown since the end of the half year. Revenues in the period were slightly up in Industrial Products.
Operating cash flow was strong with net debt at the period end of GBP146 million.
Summary and Outlook
Performance in the period has been in line with our expectations. Our NanoTechnology Tools businesses continue to perform well, although the markets served by our Industrial Products businesses remain difficult in the face of macroeconomic uncertainty.
The growing order book and strength of our NanoTechnology Tools and Service businesses support our confidence in meeting expectations for the Group for the full year.|
|This should smash through 700p tomorrow|
|Sp is moving towards a 3 month high in the long climb back to respectability , though you wonder when the next bad news will appear.|
|Disposal of Austin Scientific ("Austin")
Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, today announces that it has completed the disposal of its non-core Austin business for a cash consideration of $1.3 million.
In the six months to September 2015 Austin had revenues of GBP1.7 million and made an operating loss of GBP0.4 million.
The business was classified as discontinued and 'held for sale' in Oxford Instruments' Half Year accounts.
Hard to value loss making subsidiaries ; the buyer knows the score.|